Alzheimer's Disease / / edited by Thomas M. Wisniewski.
Alzheimer's disease (AD) is the most common cause of dementia. No effective pharmaceutical agents exist to halt or slow down the disease progression. There is a tremendous imperative to gain a better understanding of the pathogenesis of AD and to develop effective treatments. This book brings t...
Saved in:
TeilnehmendeR: | |
---|---|
Place / Publishing House: | Australia : : Exon Publications,, 2019. |
Year of Publication: | 2019 |
Language: | English |
Physical Description: | 1 online resource (1 PDF file (xvii, 255 pages)) :; illustrations |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
id |
993562314304498 |
---|---|
ctrlnum |
(CKB)4920000001372360 (NjHacI)994920000001372360 (EXLCZ)994920000001372360 |
collection |
bib_alma |
record_format |
marc |
spelling |
Alzheimer's Disease / edited by Thomas M. Wisniewski. Australia : Exon Publications, 2019. 1 online resource (1 PDF file (xvii, 255 pages)) : illustrations text txt rdacontent computer c rdamedia online resource cr rdacarrier Description based on publisher supplied metadata and other sources. Open access Unrestricted online access star Alzheimer's disease (AD) is the most common cause of dementia. No effective pharmaceutical agents exist to halt or slow down the disease progression. There is a tremendous imperative to gain a better understanding of the pathogenesis of AD and to develop effective treatments. This book brings together an international team of experts to provide a comprehensive and up-to-date overview of AD. The most current information on several critical aspects of AD are presented, providing the readers with a broad picture of the underlying neuropathology, genetics, proteomics, risk factors, novel biomarkers, and potential interventions. Chapters 1-5 discuss the underlying AD pathogenesis using genomic and proteomic approaches, linking diverse pathways that can lead to complex metabolic dysfunction. Chapter 6 reviews the potential role of trace metals in AD, while Chapter 7 examines the diversity of Aβ species involved in AD pathology. Chapter 8 discusses the contributions of white matter degeneration in AD. Chapter 9 examines the potential intriguing role of the brain-gut-microbiota axis in mediating AD. Chapters 10 and 11 discuss potential biomarkers for AD, such as deficits in ocular exploration and early language impairments, respectively. Chapters 12-15 examine possible novel preventative and/or therapeutic methodologies such as exercise, optimizing depression therapy, and diverse psychosocial interventions. The book will be of value to clinicians and health professionals caring for patients with AD, and will provide a comprehensive and thought-provoking introduction to young investigators interested in translational aspects of the AD and related dementias. Alzheimer's disease. 0-646-80968-7 Wisniewski, Thomas M., editor. |
language |
English |
format |
eBook |
author2 |
Wisniewski, Thomas M., |
author_facet |
Wisniewski, Thomas M., |
author2_variant |
t m w tm tmw |
author2_role |
TeilnehmendeR |
title |
Alzheimer's Disease / |
spellingShingle |
Alzheimer's Disease / |
title_full |
Alzheimer's Disease / edited by Thomas M. Wisniewski. |
title_fullStr |
Alzheimer's Disease / edited by Thomas M. Wisniewski. |
title_full_unstemmed |
Alzheimer's Disease / edited by Thomas M. Wisniewski. |
title_auth |
Alzheimer's Disease / |
title_new |
Alzheimer's Disease / |
title_sort |
alzheimer's disease / |
publisher |
Exon Publications, |
publishDate |
2019 |
physical |
1 online resource (1 PDF file (xvii, 255 pages)) : illustrations |
isbn |
0-646-80968-7 |
callnumber-first |
R - Medicine |
callnumber-subject |
RC - Internal Medicine |
callnumber-label |
RC523 |
callnumber-sort |
RC 3523 A494 42019 |
illustrated |
Illustrated |
dewey-hundreds |
600 - Technology |
dewey-tens |
610 - Medicine & health |
dewey-ones |
616 - Diseases |
dewey-full |
616.831 |
dewey-sort |
3616.831 |
dewey-raw |
616.831 |
dewey-search |
616.831 |
work_keys_str_mv |
AT wisniewskithomasm alzheimersdisease |
status_str |
n |
ids_txt_mv |
(CKB)4920000001372360 (NjHacI)994920000001372360 (EXLCZ)994920000001372360 |
carrierType_str_mv |
cr |
is_hierarchy_title |
Alzheimer's Disease / |
author2_original_writing_str_mv |
noLinkedField |
_version_ |
1796652002281783296 |
fullrecord |
<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>02695nam a2200301 i 4500</leader><controlfield tag="001">993562314304498</controlfield><controlfield tag="005">20231108170658.0</controlfield><controlfield tag="006">m o d </controlfield><controlfield tag="007">cr#|||||||||||</controlfield><controlfield tag="008">230224s2019 at a o 000 0 eng d</controlfield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(CKB)4920000001372360</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(NjHacI)994920000001372360</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(EXLCZ)994920000001372360</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">NjHacI</subfield><subfield code="b">eng</subfield><subfield code="e">rda</subfield><subfield code="c">NjHacl</subfield></datafield><datafield tag="050" ind1=" " ind2="4"><subfield code="a">RC523</subfield><subfield code="b">.A494 2019</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">616.831</subfield><subfield code="2">23</subfield></datafield><datafield tag="245" ind1="0" ind2="0"><subfield code="a">Alzheimer's Disease /</subfield><subfield code="c">edited by Thomas M. Wisniewski.</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="a">Australia :</subfield><subfield code="b">Exon Publications,</subfield><subfield code="c">2019.</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">1 online resource (1 PDF file (xvii, 255 pages)) :</subfield><subfield code="b">illustrations</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">text</subfield><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">computer</subfield><subfield code="b">c</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">online resource</subfield><subfield code="b">cr</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="588" ind1=" " ind2=" "><subfield code="a">Description based on publisher supplied metadata and other sources.</subfield></datafield><datafield tag="506" ind1=" " ind2=" "><subfield code="a">Open access</subfield><subfield code="f">Unrestricted online access</subfield><subfield code="2">star</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">Alzheimer's disease (AD) is the most common cause of dementia. No effective pharmaceutical agents exist to halt or slow down the disease progression. There is a tremendous imperative to gain a better understanding of the pathogenesis of AD and to develop effective treatments. This book brings together an international team of experts to provide a comprehensive and up-to-date overview of AD. The most current information on several critical aspects of AD are presented, providing the readers with a broad picture of the underlying neuropathology, genetics, proteomics, risk factors, novel biomarkers, and potential interventions. Chapters 1-5 discuss the underlying AD pathogenesis using genomic and proteomic approaches, linking diverse pathways that can lead to complex metabolic dysfunction. Chapter 6 reviews the potential role of trace metals in AD, while Chapter 7 examines the diversity of Aβ species involved in AD pathology. Chapter 8 discusses the contributions of white matter degeneration in AD. Chapter 9 examines the potential intriguing role of the brain-gut-microbiota axis in mediating AD. Chapters 10 and 11 discuss potential biomarkers for AD, such as deficits in ocular exploration and early language impairments, respectively. Chapters 12-15 examine possible novel preventative and/or therapeutic methodologies such as exercise, optimizing depression therapy, and diverse psychosocial interventions. The book will be of value to clinicians and health professionals caring for patients with AD, and will provide a comprehensive and thought-provoking introduction to young investigators interested in translational aspects of the AD and related dementias.</subfield></datafield><datafield tag="650" ind1=" " ind2="0"><subfield code="a">Alzheimer's disease.</subfield></datafield><datafield tag="776" ind1=" " ind2=" "><subfield code="z">0-646-80968-7</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Wisniewski, Thomas M.,</subfield><subfield code="e">editor.</subfield></datafield><datafield tag="906" ind1=" " ind2=" "><subfield code="a">BOOK</subfield></datafield><datafield tag="ADM" ind1=" " ind2=" "><subfield code="b">2023-11-09 11:42:46 Europe/Vienna</subfield><subfield code="f">system</subfield><subfield code="c">marc21</subfield><subfield code="a">2022-09-22 08:09:39 Europe/Vienna</subfield><subfield code="g">false</subfield></datafield><datafield tag="AVE" ind1=" " ind2=" "><subfield code="i">DOAB Directory of Open Access Books</subfield><subfield code="P">DOAB Directory of Open Access Books</subfield><subfield code="x">https://eu02.alma.exlibrisgroup.com/view/uresolver/43ACC_OEAW/openurl?u.ignore_date_coverage=true&portfolio_pid=5338263590004498&Force_direct=true</subfield><subfield code="Z">5338263590004498</subfield><subfield code="b">Available</subfield><subfield code="8">5338263590004498</subfield></datafield></record></collection> |